Company intelligence / Profile preview
LTL Pharma
Tokyo/Shinjuku-ku/Nishi-Shinjuku area, Tokyo-to/Tokyo Prefecture, Japanltl-pharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
LTL Pharma specializes in the stable supply of long-listed ethical drugs ("Long-life Medicines") that have established safety and efficacy profiles. The company acquires mature brands from major pharma companies to ensure continued access for patients. Recent clinical results are not typically generated by the company itself as it focuses on marketed products with established data.
- Therapeutic areas
- EndocrinologyImmunologyPsychiatryCardiovascularInfectious Diseases
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Partnerships with local distributors in at least sixteen countries for overseas businessproduct acquisition partnerships with Astellas Pharma Inc.product acquisition partnerships with Chugai Pharmaceutical/Roche for specific assets such as Oxarol Injection
Beyond the preview
Go deeper on LTL Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LTL Pharma.